Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL

Name: Phase 2 Study of AFM13 in Combination With AB-101 in Subjects With R/R HL and CD30+ PTCL
License: Public Domain

Affimed GmbH

ClinicalTrials.gov · Datasets · License: Public Domain

relapsed or refractory hodgkin lymphoma, peripheral t cell lymphoma

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 387156
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.